Entity Type
Company
Filer Snapshot
TEVA PHARMACEUTICAL INDUSTRIES LTD SEC EDGAR Filings
SEC filings, ownership reports, and insider transactions for CIK 0000818686.
Total Filings
2,476
Latest Filing
07 May 2026
Industry
Pharmaceutical Preparations
Save this filer page for the next filing cycle
Keep this page in your research queue, then return to compare new filings with prior context.
Save and revisit
Save this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Best next steps
Start with the latest filings table, then open the strongest context page for this filer.
- Use the filings table to verify the newest submission, form type, and report period.
- Open the deeper context page only when this filer actually has insider or ownership signal.
Source: SEC Forms 3/4/5
View Source Filing
4 filed on 07 May 2026 for CIK 0000818686.
- Symbol
- TEVA on NYSE, TEVJF on OTC
- Business address
- Teva Pharmaceutical Industries Limited, 124 Dvora Hanevi'a St., Tel Aviv
- State of incorporation
- Israel
- Fiscal year end
- 31 December
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED (to 16 Jan 2001)
Quick Takeaways
- TEVA PHARMACEUTICAL INDUSTRIES LTD is an SEC filer tracked under CIK 0000818686.
- 2,476 filings are listed on this profile.
- Common form coverage includes 4, 144, 10-Q and more.
What Changed
- Latest filing: 4 filed on 07 May 2026.
- Report period: 06 May 2026.
Why This Matters
- You can quote filing dates and form types directly from the SEC record on this page.
- Use this profile before deeper ownership or insider analysis to confirm filing history context.
Source Evidence
Source: SEC Forms 3/4/5
View Source Filing
4 filed on 07 May 2026 for CIK 0000818686.
Return Loop
Why revisit this filer page
A newly filed 4 can change the filing history, ownership context, or next research path for TEVA PHARMACEUTICAL INDUSTRIES LTD.
- Latest source-backed update
- 4 filed 07 May 2026
- Why come back
- Revisit after a new SEC filing appears to compare the updated record with prior filings.
- Latest filing on record: 4 filed 07 May 2026.
- Save this filer if you want a stable place to return after the next filing cycle.
- Open the latest filing table or ownership context to verify what changed.
Filer freshness comes from SEC EDGAR submission history and related source-backed ownership or portfolio filings when available.
Latest update
What changed recently for TEVA PHARMACEUTICAL INDUSTRIES LTD
Latest financial period: Q1 2026. Open the source-backed page to inspect the fresh filing or facts context.
Update date
29 Apr 2026
Page type
Company facts
Latest period
Q1 2026
SEC-backed company facts were refreshed from filings filed on 29 Apr 2026.
Benchmark Context
Benchmark context for this company
TEVA PHARMACEUTICAL INDUSTRIES LTD has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.
Compared with
Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.
Why this is notable
Latest financial period: Q1 2026. That gives you a fresh baseline before you compare this company with peers.
- Latest company facts filing date: 29 Apr 2026.
- Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
- Open the facts page first if you want the cleanest path to verification.
Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.
Company intelligence
Research TEVA PHARMACEUTICAL INDUSTRIES LTD from filings to ownership signals
Use this company page as the hub for SEC filings, fundamentals, insider activity, large-stake holders, and institutional ownership context.
Active modules
3/5
Available company intelligence paths on this page.
Filings
2,476
SEC submissions provide the evidence trail.
Ownership context
1/3
Insider, large-stake, and institutional ownership lanes.
Return loop
Watch
Save the company so the next source-backed change has a clear place to bring you back.
Best-of company intelligence workflow
What changed?
Start with the latest filing and active ownership modules before opening older table rows.
Why might it matter?
Use insider, 13D/G, and 13F context to separate routine filings from ownership signals.
Where is evidence?
Keep SEC source documents one click away through filings, facts, insider reports, and Schedule 13D/G records.
What to watch next?
Save the company so watchlists can bring you back when the next filing-backed update lands.
SEC-verifiable company research path
Every company hub should answer what changed, why ownership activity might matter, where SEC evidence lives, and which filer, insider, holder, or filing page deserves the next click.
SEC filings
AvailableLatest company filings
Start with the filing timeline to verify the newest source document and report period.
Company facts
AvailableFinancial context
Use XBRL facts when ownership activity needs revenue, earnings, debt, or cash-flow context.
Forms 3/4/5
AvailableInsider activity
Check whether directors, officers, or 10% owners are buying, selling, or filing fresh ownership changes.
Schedule 13D/G
ExploreLarge-stake holders
Review beneficial ownership filings for activist-style or passive large holder changes around this issuer.
Form 13F
ExploreInstitutional holders
Compare manager filings and smart-money context when company-level ownership needs broader holders.
SEC-verifiable company hub
The strongest research path is the one that keeps source documents close: filings first, then ownership signals, insider context, and fundamentals.
Watchlist return triggers
Watch TEVA PHARMACEUTICAL INDUSTRIES LTD when any filing-backed ownership signal appears, then jump back into the exact SEC evidence path.
new company filing
insider Form 4
13D/G holder change
13F holder update
Filer Overview
TEVA PHARMACEUTICAL INDUSTRIES LTD has filed 2,476 SEC EDGAR filings since 02 Feb 1996. Common forms include 4, 144, 10-Q, 8-K and more.
Latest Filings
Recent SEC filings for TEVA PHARMACEUTICAL INDUSTRIES LTD with direct links to document and filing folders.
| Form type | Document | Filing | Description | Filing date | Reporting date | File number(s) |
|---|---|---|---|---|---|---|
| 4 | Open 4 document | View SEC filing for 4 | 4 | 07 May 2026 | 06 May 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 07 May 2026 | 05 May 2026 | |
| 144 | Open 144 document | View SEC filing for 144 | 05 May 2026 | 001-16174 | ||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 04 May 2026 | 01 May 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 04 May 2026 | 30 Apr 2026 | |
| 144 | Open 144 document | View SEC filing for 144 | 04 May 2026 | 001-16174 | ||
| 144 | Open 144 document | View SEC filing for 144 | 30 Apr 2026 | 001-16174 | ||
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 29 Apr 2026 | 31 Mar 2026 | 001-16174 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | FORM 8-K | 29 Apr 2026 | 29 Apr 2026 | 001-16174 |
| DEFA14A | Open DEFA14A document | View SEC filing for DEFA14A | DEFA14A | 31 Mar 2026 | 001-16174 | |
| ARS | Open ARS document | View SEC filing for ARS | ARS | 31 Mar 2026 | 31 Dec 2025 | 001-16174 |
| DEF 14A | Open DEF 14A document | Open XBRL data | View SEC filing for DEF 14A | DEF 14A | 31 Mar 2026 | 28 May 2026 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 19 Mar 2026 | 17 Mar 2026 | |
| 144 | Open 144 document | View SEC filing for 144 | 17 Mar 2026 | 001-16174 | ||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 09 Mar 2026 | 05 Mar 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 09 Mar 2026 | 05 Mar 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 09 Mar 2026 | 05 Mar 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 09 Mar 2026 | 05 Mar 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 09 Mar 2026 | 05 Mar 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 09 Mar 2026 | 05 Mar 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 09 Mar 2026 | 05 Mar 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 09 Mar 2026 | 05 Mar 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 09 Mar 2026 | 05 Mar 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 09 Mar 2026 | 05 Mar 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 06 Mar 2026 | 04 Mar 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 06 Mar 2026 | 04 Mar 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 06 Mar 2026 | 04 Mar 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 06 Mar 2026 | 04 Mar 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 06 Mar 2026 | 04 Mar 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 06 Mar 2026 | 04 Mar 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 06 Mar 2026 | 04 Mar 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 06 Mar 2026 | 04 Mar 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 06 Mar 2026 | 04 Mar 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 06 Mar 2026 | 04 Mar 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 06 Mar 2026 | 04 Mar 2026 | |
| 144 | Open 144 document | View SEC filing for 144 | 05 Mar 2026 | 001-16174 | ||
| 144 | Open 144 document | View SEC filing for 144 | 05 Mar 2026 | 001-16174 | ||
| 144 | Open 144 document | View SEC filing for 144 | 05 Mar 2026 | 001-16174 | ||
| 144 | Open 144 document | View SEC filing for 144 | 05 Mar 2026 | 001-16174 | ||
| 144 | Open 144 document | View SEC filing for 144 | 05 Mar 2026 | 001-16174 | ||
| 144 | Open 144 document | View SEC filing for 144 | 05 Mar 2026 | 001-16174 | ||
| 144 | Open 144 document | View SEC filing for 144 | 05 Mar 2026 | 001-16174 | ||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 05 Mar 2026 | 03 Mar 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 05 Mar 2026 | 03 Mar 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 05 Mar 2026 | 03 Mar 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 05 Mar 2026 | 03 Mar 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 05 Mar 2026 | 03 Mar 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 05 Mar 2026 | 03 Mar 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 05 Mar 2026 | 03 Mar 2026 | |
| 144 | Open 144 document | View SEC filing for 144 | 04 Mar 2026 | 001-16174 | ||
| 144 | Open 144 document | View SEC filing for 144 | 04 Mar 2026 | 001-16174 | ||
| 144 | Open 144 document | View SEC filing for 144 | 04 Mar 2026 | 001-16174 | ||
| 144 | Open 144 document | View SEC filing for 144 | 04 Mar 2026 | 001-16174 | ||
| 144 | Open 144 document | View SEC filing for 144 | 03 Mar 2026 | 001-16174 | ||
| 144 | Open 144 document | View SEC filing for 144 | 03 Mar 2026 | 001-16174 | ||
| 144 | Open 144 document | View SEC filing for 144 | 03 Mar 2026 | 001-16174 | ||
| 144 | Open 144 document | View SEC filing for 144 | 03 Mar 2026 | 001-16174 | ||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 02 Mar 2026 | 26 Feb 2026 | |
| 144 | Open 144 document | View SEC filing for 144 | 26 Feb 2026 | 001-16174 | ||
| 3 | Open 3 document | View SEC filing for 3 | 3 | 23 Feb 2026 | 11 Feb 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 18 Feb 2026 | 15 Feb 2026 | |
| 144/A | Open 144/A document | View SEC filing for 144/A | 18 Feb 2026 | 001-16174 | ||
| 144 | Open 144 document | View SEC filing for 144 | 18 Feb 2026 | 001-16174 | ||
| SCHEDULE 13G | Open SCHEDULE 13G document | View SEC filing for SCHEDULE 13G | 17 Feb 2026 | 005-55457 | ||
| SCHEDULE 13G/A | Open SCHEDULE 13G/A document | View SEC filing for SCHEDULE 13G/A | 09 Feb 2026 | 005-55457 | ||
| 10-K | Open 10-K document | Open XBRL data | View SEC filing for 10-K | 10-K | 03 Feb 2026 | 31 Dec 2025 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 29 Jan 2026 | 27 Jan 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 29 Jan 2026 | 27 Jan 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 29 Jan 2026 | 27 Jan 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 29 Jan 2026 | 27 Jan 2026 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 29 Jan 2026 | 27 Jan 2026 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | FORM 8-K | 28 Jan 2026 | 28 Jan 2026 | 001-16174 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | FORM 8-K | 12 Jan 2026 | 11 Jan 2026 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 18 Dec 2025 | 16 Dec 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 18 Dec 2025 | 16 Dec 2025 | |
| 144 | Open 144 document | View SEC filing for 144 | 12 Dec 2025 | 001-16174 | ||
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 11 Dec 2025 | 10 Dec 2025 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 11 Dec 2025 | 09 Dec 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 11 Dec 2025 | 09 Dec 2025 | |
| 144 | Open 144 document | View SEC filing for 144 | 09 Dec 2025 | 001-16174 | ||
| 144 | Open 144 document | View SEC filing for 144 | 09 Dec 2025 | 001-16174 | ||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 04 Dec 2025 | 02 Dec 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 01 Dec 2025 | 26 Nov 2025 | |
| 144 | Open 144 document | View SEC filing for 144 | 26 Nov 2025 | 001-16174 | ||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 24 Nov 2025 | 20 Nov 2025 | |
| 144 | Open 144 document | View SEC filing for 144 | 20 Nov 2025 | 001-16174 | ||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 18 Nov 2025 | 14 Nov 2025 | |
| 144 | Open 144 document | View SEC filing for 144 | 14 Nov 2025 | 001-16174 | ||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 10 Nov 2025 | 06 Nov 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 10 Nov 2025 | 06 Nov 2025 | |
| 144/A | Open 144/A document | View SEC filing for 144/A | 06 Nov 2025 | 001-16174 | ||
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 05 Nov 2025 | 30 Sep 2025 | 001-16174 |
| SCHEDULE 13G/A | Open SCHEDULE 13G/A document | View SEC filing for SCHEDULE 13G/A | 05 Nov 2025 | 005-55457 | ||
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | FORM 8-K | 05 Nov 2025 | 05 Nov 2025 | 001-16174 |
| SCHEDULE 13G | Open SCHEDULE 13G document | View SEC filing for SCHEDULE 13G | 06 Oct 2025 | 005-55457 | ||
| 144 | Open 144 document | View SEC filing for 144 | 12 Sep 2025 | 001-16174 | ||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 09 Sep 2025 | 05 Sep 2025 | |
| SCHEDULE 13G/A | Open SCHEDULE 13G/A document | View SEC filing for SCHEDULE 13G/A | 06 Aug 2025 | 005-55457 | ||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 05 Aug 2025 | 01 Aug 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 05 Aug 2025 | 01 Aug 2025 | |
| 144 | Open 144 document | View SEC filing for 144 | 01 Aug 2025 | 001-16174 | ||
| 144 | Open 144 document | View SEC filing for 144 | 01 Aug 2025 | 001-16174 | ||
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 30 Jul 2025 | 30 Jun 2025 | 001-16174 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | FORM 8-K | 30 Jul 2025 | 30 Jul 2025 | 001-16174 |
| SCHEDULE 13G | Open SCHEDULE 13G document | View SEC filing for SCHEDULE 13G | 22 Jul 2025 | 005-55457 | ||
| SCHEDULE 13G | Open SCHEDULE 13G document | View SEC filing for SCHEDULE 13G | 17 Jul 2025 | 005-55457 | ||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 16 Jun 2025 | 12 Jun 2025 | |
| 144 | Open 144 document | View SEC filing for 144 | 12 Jun 2025 | 001-16174 | ||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 09 Jun 2025 | 05 Jun 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 09 Jun 2025 | 05 Jun 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 09 Jun 2025 | 05 Jun 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 09 Jun 2025 | 05 Jun 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 09 Jun 2025 | 05 Jun 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 09 Jun 2025 | 05 Jun 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 09 Jun 2025 | 05 Jun 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 09 Jun 2025 | 05 Jun 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 09 Jun 2025 | 05 Jun 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 09 Jun 2025 | 05 Jun 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 09 Jun 2025 | 05 Jun 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 09 Jun 2025 | 05 Jun 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 05 Jun 2025 | 03 Jun 2025 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 05 Jun 2025 | 05 Jun 2025 | 001-16174 |
| 144 | Open 144 document | View SEC filing for 144 | 03 Jun 2025 | 001-16174 | ||
| SD | Open SD document | View SEC filing for SD | SD | 02 Jun 2025 | 001-16174 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 28 May 2025 | 28 May 2025 | 001-16174 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 22 May 2025 | 20 May 2025 | 001-16174 |
| 424B5 | Open 424B5 document | Open XBRL data | View SEC filing for 424B5 | 424B5 | 22 May 2025 | 333-284770 | |
| FWP | Open FWP document | View SEC filing for FWP | FWP | 20 May 2025 | 333-284770 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 19 May 2025 | 14 May 2025 | |
| 424B5 | Open 424B5 document | View SEC filing for 424B5 | 424B5 | 19 May 2025 | 333-284770 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 12 May 2025 | 08 May 2025 | |
| 144 | Open 144 document | View SEC filing for 144 | 08 May 2025 | 001-16174 | ||
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 07 May 2025 | 31 Mar 2025 | 001-16174 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | FORM 8-K | 07 May 2025 | 07 May 2025 | 001-16174 |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 28 Apr 2025 | 001-16174 | ||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 14 Apr 2025 | |||
| DEFA14A | Open DEFA14A document | View SEC filing for DEFA14A | DEFA14A | 09 Apr 2025 | 001-16174 | |
| ARS | Open ARS document | View SEC filing for ARS | ARS | 09 Apr 2025 | 31 Dec 2024 | 001-16174 |
| DEF 14A | Open DEF 14A document | Open XBRL data | View SEC filing for DEF 14A | DEF 14A | 09 Apr 2025 | 05 Jun 2025 | 001-16174 |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 07 Apr 2025 | 001-16174 | ||
| 3 | Open 3 document | View SEC filing for 3 | 3 | 07 Apr 2025 | 31 Mar 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 07 Mar 2025 | 05 Mar 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 07 Mar 2025 | 05 Mar 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 07 Mar 2025 | 05 Mar 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 07 Mar 2025 | 05 Mar 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 07 Mar 2025 | 05 Mar 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 07 Mar 2025 | 05 Mar 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 07 Mar 2025 | 05 Mar 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 07 Mar 2025 | 05 Mar 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 07 Mar 2025 | 05 Mar 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 07 Mar 2025 | 05 Mar 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 06 Mar 2025 | 04 Mar 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 06 Mar 2025 | 04 Mar 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 06 Mar 2025 | 04 Mar 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 06 Mar 2025 | 04 Mar 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 06 Mar 2025 | 04 Mar 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 06 Mar 2025 | 04 Mar 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 06 Mar 2025 | 04 Mar 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 06 Mar 2025 | 04 Mar 2025 | |
| 144 | Open 144 document | View SEC filing for 144 | 05 Mar 2025 | 001-16174 | ||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 05 Mar 2025 | 03 Mar 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 05 Mar 2025 | 03 Mar 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 05 Mar 2025 | 03 Mar 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 05 Mar 2025 | 03 Mar 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 05 Mar 2025 | 03 Mar 2025 | |
| 144/A | Open 144/A document | View SEC filing for 144/A | 04 Mar 2025 | 001-16174 | ||
| 144 | Open 144 document | View SEC filing for 144 | 04 Mar 2025 | 001-16174 | ||
| 144 | Open 144 document | View SEC filing for 144 | 04 Mar 2025 | 001-16174 | ||
| 144 | Open 144 document | View SEC filing for 144 | 04 Mar 2025 | 001-16174 | ||
| 144 | Open 144 document | View SEC filing for 144 | 04 Mar 2025 | 001-16174 | ||
| 144 | Open 144 document | View SEC filing for 144 | 04 Mar 2025 | 001-16174 | ||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 04 Mar 2025 | 28 Feb 2025 | |
| 144 | Open 144 document | View SEC filing for 144 | 03 Mar 2025 | 001-16174 | ||
| 144 | Open 144 document | View SEC filing for 144 | 03 Mar 2025 | 001-16174 | ||
| 144 | Open 144 document | View SEC filing for 144 | 03 Mar 2025 | 001-16174 | ||
| 144 | Open 144 document | View SEC filing for 144 | 28 Feb 2025 | 001-16174 | ||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 19 Feb 2025 | 15 Feb 2025 | |
| 144 | Open 144 document | View SEC filing for 144 | 18 Feb 2025 | 001-16174 | ||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 14 Feb 2025 | 12 Feb 2025 | |
| 144 | Open 144 document | View SEC filing for 144 | 13 Feb 2025 | 001-16174 | ||
| SCHEDULE 13G/A | Open SCHEDULE 13G/A document | View SEC filing for SCHEDULE 13G/A | 12 Feb 2025 | 005-55457 | ||
| S-3ASR | Open S-3ASR document | Open XBRL data | View SEC filing for S-3ASR | S-3ASR | 07 Feb 2025 | 333-284770 | |
| 10-K | Open 10-K document | Open XBRL data | View SEC filing for 10-K | 10-K | 05 Feb 2025 | 31 Dec 2024 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 30 Jan 2025 | 28 Jan 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 30 Jan 2025 | 28 Jan 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 30 Jan 2025 | 28 Jan 2025 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | FORM 8-K | 29 Jan 2025 | 29 Jan 2025 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 26 Dec 2024 | 20 Dec 2024 | |
| 144 | Open 144 document | View SEC filing for 144 | 20 Dec 2024 | 001-16174 | ||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 04 Dec 2024 | 02 Dec 2024 | |
| 3 | Open 3 document | View SEC filing for 3 | 3 | 04 Dec 2024 | 01 Dec 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 21 Nov 2024 | 20 Nov 2024 | |
| 144 | Open 144 document | View SEC filing for 144 | 20 Nov 2024 | 001-16174 | ||
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 12 Nov 2024 | 05 Nov 2024 | 001-16174 |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | 12 Nov 2024 | 005-55457 | ||
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 06 Nov 2024 | 30 Sep 2024 | 001-16174 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | FORM 8-K | 06 Nov 2024 | 06 Nov 2024 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 04 Sep 2024 | 02 Sep 2024 | |
| 144/A | Open 144/A document | View SEC filing for 144/A | 14 Aug 2024 | 001-16174 | ||
| 144/A | Open 144/A document | View SEC filing for 144/A | 14 Aug 2024 | 001-16174 | ||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 13 Aug 2024 | 12 Aug 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 13 Aug 2024 | 09 Aug 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 13 Aug 2024 | 09 Aug 2024 | |
| 144 | Open 144 document | View SEC filing for 144 | 12 Aug 2024 | 001-16174 | ||
| 144 | Open 144 document | View SEC filing for 144 | 12 Aug 2024 | 001-16174 | ||
| 144 | Open 144 document | View SEC filing for 144 | 09 Aug 2024 | 001-16174 | ||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 05 Aug 2024 | 01 Aug 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 05 Aug 2024 | 01 Aug 2024 | |
| 3 | Open 3 document | View SEC filing for 3 | 3 | 05 Aug 2024 | 01 Aug 2024 | |
| 144 | Open 144 document | View SEC filing for 144 | 01 Aug 2024 | 001-16174 | ||
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 31 Jul 2024 | 30 Jun 2024 | 001-16174 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | FORM 8-K | 31 Jul 2024 | 31 Jul 2024 | 001-16174 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 25 Jun 2024 | 23 Jun 2024 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 21 Jun 2024 | 18 Jun 2024 | |
| 144 | Open 144 document | View SEC filing for 144 | 18 Jun 2024 | 001-16174 | ||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 17 Jun 2024 | 15 Jun 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 17 Jun 2024 | 15 Jun 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 17 Jun 2024 | 15 Jun 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 17 Jun 2024 | 15 Jun 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 17 Jun 2024 | 15 Jun 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 17 Jun 2024 | 15 Jun 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 17 Jun 2024 | 15 Jun 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 17 Jun 2024 | 15 Jun 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 17 Jun 2024 | 15 Jun 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 10 Jun 2024 | 06 Jun 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 10 Jun 2024 | 06 Jun 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 10 Jun 2024 | 06 Jun 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 10 Jun 2024 | 06 Jun 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 10 Jun 2024 | 06 Jun 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 10 Jun 2024 | 06 Jun 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 10 Jun 2024 | 06 Jun 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 10 Jun 2024 | 06 Jun 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 10 Jun 2024 | 06 Jun 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 10 Jun 2024 | 06 Jun 2024 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 06 Jun 2024 | 06 Jun 2024 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 05 Jun 2024 | 03 Jun 2024 | |
| 3 | Open 3 document | View SEC filing for 3 | 3 | 05 Jun 2024 | 03 Jun 2024 | |
| SD | Open SD document | View SEC filing for SD | FORM SD | 30 May 2024 | 001-16174 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 17 May 2024 | 15 May 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 15 May 2024 | 13 May 2024 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 15 May 2024 | 15 May 2024 | 001-16174 |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 08 May 2024 | 31 Mar 2024 | 001-16174 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 08 May 2024 | 08 May 2024 | 001-16174 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 18 Apr 2024 | 18 Apr 2024 | 001-16174 |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 17 Apr 2024 | 001-16174 | ||
| DEFA14A | Open DEFA14A document | View SEC filing for DEFA14A | DEFA14A | 16 Apr 2024 | 001-16174 | |
| ARS | Open ARS document | View SEC filing for ARS | ARS | 16 Apr 2024 | 31 Dec 2023 | 001-16174 |
| DEF 14A | Open DEF 14A document | Open XBRL data | View SEC filing for DEF 14A | DEF 14A | 16 Apr 2024 | 06 Jun 2024 | 001-16174 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13-G/A | 09 Apr 2024 | 005-55457 | |
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 08 Apr 2024 | |||
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 11 Mar 2024 | 001-16174 | ||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 07 Mar 2024 | 05 Mar 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 07 Mar 2024 | 05 Mar 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 07 Mar 2024 | 05 Mar 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 07 Mar 2024 | 05 Mar 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 07 Mar 2024 | 05 Mar 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 07 Mar 2024 | 05 Mar 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 05 Mar 2024 | 04 Mar 2024 | |
| 3 | Open 3 document | View SEC filing for 3 | 3 | 05 Mar 2024 | 04 Mar 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 05 Mar 2024 | 03 Mar 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 05 Mar 2024 | 04 Mar 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 05 Mar 2024 | 04 Mar 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 05 Mar 2024 | 03 Mar 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 05 Mar 2024 | 03 Mar 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 05 Mar 2024 | 03 Mar 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 05 Mar 2024 | 03 Mar 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 05 Mar 2024 | 03 Mar 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 05 Mar 2024 | 03 Mar 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 05 Mar 2024 | 03 Mar 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 01 Mar 2024 | 28 Feb 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 01 Mar 2024 | 28 Feb 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 01 Mar 2024 | 28 Feb 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 01 Mar 2024 | 28 Feb 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 01 Mar 2024 | 28 Feb 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 01 Mar 2024 | 28 Feb 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 01 Mar 2024 | 28 Feb 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 21 Feb 2024 | 16 Feb 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 20 Feb 2024 | 15 Feb 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 15 Feb 2024 | 13 Feb 2024 | |
| 10-K | Open 10-K document | Open XBRL data | View SEC filing for 10-K | 10-K | 12 Feb 2024 | 31 Dec 2023 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 05 Feb 2024 | 01 Feb 2024 | |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | SC 13-G | 01 Feb 2024 | 005-55457 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 01 Feb 2024 | 30 Jan 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 01 Feb 2024 | 30 Jan 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 01 Feb 2024 | 30 Jan 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | 4 | 01 Feb 2024 | 30 Jan 2024 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K | 31 Jan 2024 | 31 Jan 2024 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 22 Nov 2023 | 20 Nov 2023 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 22 Nov 2023 | 20 Nov 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 16 Nov 2023 | 15 Nov 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 16 Nov 2023 | 15 Nov 2023 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 09 Nov 2023 | 30 Sep 2023 | 001-16174 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K | 08 Nov 2023 | 08 Nov 2023 | 001-16174 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 18 Oct 2023 | 13 Oct 2023 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 05 Oct 2023 | 25 Sep 2023 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 04 Oct 2023 | 04 Oct 2023 | 001-16174 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 28 Sep 2023 | 25 Sep 2023 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 05 Sep 2023 | 02 Sep 2023 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 05 Sep 2023 | 01 Sep 2023 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 24 Aug 2023 | 21 Aug 2023 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 10 Aug 2023 | 09 Aug 2023 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 10 Aug 2023 | 01 Aug 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 09 Aug 2023 | 07 Aug 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Aug 2023 | 04 Aug 2023 | |
| 4/A | Open 4/A document | View SEC filing for 4/A | FORM 4/A SUBMISSION | 07 Aug 2023 | 03 Mar 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Aug 2023 | 04 Aug 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Aug 2023 | 04 Aug 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Aug 2023 | 04 Aug 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Aug 2023 | 04 Aug 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Aug 2023 | 04 Aug 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Aug 2023 | 04 Aug 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Aug 2023 | 04 Aug 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Aug 2023 | 04 Aug 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Aug 2023 | 04 Aug 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 03 Aug 2023 | 01 Aug 2023 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 02 Aug 2023 | 01 Aug 2023 | 001-16174 |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 02 Aug 2023 | 30 Jun 2023 | 001-16174 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K | 02 Aug 2023 | 02 Aug 2023 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Jun 2023 | 15 Jun 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Jun 2023 | 15 Jun 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Jun 2023 | 15 Jun 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Jun 2023 | 15 Jun 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Jun 2023 | 15 Jun 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Jun 2023 | 15 Jun 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Jun 2023 | 15 Jun 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Jun 2023 | 15 Jun 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Jun 2023 | 15 Jun 2023 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 15 Jun 2023 | 15 Jun 2023 | 001-16174 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SEC SCHEDULE 13G | 09 Jun 2023 | 005-55457 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 08 Jun 2023 | 08 Jun 2023 | 001-16174 |
| DEFA14A | Open DEFA14A document | View SEC filing for DEFA14A | DEFA14A | 24 May 2023 | 001-16174 | |
| SD | Open SD document | View SEC filing for SD | SD | 24 May 2023 | 001-16174 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 11 May 2023 | 08 May 2023 | 001-16174 |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 10 May 2023 | 31 Mar 2023 | 001-16174 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K | 10 May 2023 | 10 May 2023 | 001-16174 |
| ARS | Open ARS document | View SEC filing for ARS | ARS | 19 Apr 2023 | 31 Dec 2022 | 001-16174 |
| DEFA14A | Open DEFA14A document | View SEC filing for DEFA14A | DEFA14A | 19 Apr 2023 | 001-16174 | |
| DEF 14A | Open DEF 14A document | Open XBRL data | View SEC filing for DEF 14A | DEF 14A | 19 Apr 2023 | 001-16174 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 09 Mar 2023 | 09 Mar 2023 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Mar 2023 | 06 Mar 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Mar 2023 | 06 Mar 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Mar 2023 | 06 Mar 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Mar 2023 | 06 Mar 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Mar 2023 | 03 Mar 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Mar 2023 | 03 Mar 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Mar 2023 | 03 Mar 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Mar 2023 | 03 Mar 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Mar 2023 | 03 Mar 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Mar 2023 | 03 Mar 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Mar 2023 | 03 Mar 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Mar 2023 | 03 Mar 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Mar 2023 | 03 Mar 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Mar 2023 | 03 Mar 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Mar 2023 | 03 Mar 2023 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 03 Mar 2023 | 01 Mar 2023 | 001-16174 |
| 424B5 | Open 424B5 document | View SEC filing for 424B5 | 424B5 | 03 Mar 2023 | 333-260519 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Mar 2023 | 28 Feb 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Mar 2023 | 28 Feb 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Mar 2023 | 28 Feb 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Mar 2023 | 28 Feb 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Mar 2023 | 28 Feb 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Mar 2023 | 28 Feb 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Mar 2023 | 28 Feb 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Mar 2023 | 28 Feb 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Mar 2023 | 28 Feb 2023 | |
| FWP | Open FWP document | View SEC filing for FWP | FWP | 01 Mar 2023 | 333-260519 | |
| 424B5 | Open 424B5 document | View SEC filing for 424B5 | 424B5 | 27 Feb 2023 | 333-260519 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 17 Feb 2023 | 15 Feb 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 15 Feb 2023 | 13 Feb 2023 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SEC SCHEDULE 13G | 13 Feb 2023 | 005-55457 | |
| 10-K | Open 10-K document | Open XBRL data | View SEC filing for 10-K | FORM 10-K | 10 Feb 2023 | 31 Dec 2022 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 09 Feb 2023 | 07 Feb 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 09 Feb 2023 | 07 Feb 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 09 Feb 2023 | 07 Feb 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 09 Feb 2023 | 07 Feb 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 09 Feb 2023 | 07 Feb 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 09 Feb 2023 | 07 Feb 2023 | |
| F-6EF | Open F-6EF document | View SEC filing for F-6EF | 08 Feb 2023 | 333-269640 | ||
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K | 08 Feb 2023 | 08 Feb 2023 | 001-16174 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 03 Jan 2023 | 01 Jan 2023 | |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 21 Dec 2022 | |||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 20 Dec 2022 | |||
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 01 Dec 2022 | |||
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 21 Nov 2022 | 18 Nov 2022 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Nov 2022 | 04 Nov 2022 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 03 Nov 2022 | 30 Sep 2022 | 001-16174 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K | 03 Nov 2022 | 03 Nov 2022 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Nov 2022 | 01 Nov 2022 | |
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 26 Oct 2022 | |||
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 13 Sep 2022 | |||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 24 Aug 2022 | 22 Aug 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 11 Aug 2022 | 10 Aug 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Aug 2022 | 04 Aug 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Aug 2022 | 04 Aug 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Aug 2022 | 04 Aug 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Aug 2022 | 04 Aug 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Aug 2022 | 04 Aug 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Aug 2022 | 04 Aug 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Aug 2022 | 04 Aug 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Aug 2022 | 04 Aug 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Aug 2022 | 04 Aug 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Aug 2022 | 04 Aug 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Aug 2022 | 04 Aug 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 03 Aug 2022 | 01 Aug 2022 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 03 Aug 2022 | 01 Aug 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 29 Jul 2022 | 28 Jul 2022 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 27 Jul 2022 | 30 Jun 2022 | 001-16174 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K | 26 Jul 2022 | 26 Jul 2022 | 001-16174 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 23 Jun 2022 | 23 Jun 2022 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 16 Jun 2022 | 14 Jun 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 16 Jun 2022 | 14 Jun 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 16 Jun 2022 | 14 Jun 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 16 Jun 2022 | 14 Jun 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 16 Jun 2022 | 14 Jun 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 16 Jun 2022 | 14 Jun 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 16 Jun 2022 | 14 Jun 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 16 Jun 2022 | 14 Jun 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 16 Jun 2022 | 14 Jun 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 16 Jun 2022 | 14 Jun 2022 | |
| SD | Open SD document | View SEC filing for SD | SD | 25 May 2022 | 001-16174 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 19 May 2022 | 17 May 2022 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 03 May 2022 | 31 Mar 2022 | 001-16174 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K | 03 May 2022 | 03 May 2022 | 001-16174 |
| DEFA14A | Open DEFA14A document | View SEC filing for DEFA14A | DEFA14A | 13 Apr 2022 | 001-16174 | |
| DEF 14A | Open DEF 14A document | View SEC filing for DEF 14A | DEF 14A | 13 Apr 2022 | 23 Jun 2022 | 001-16174 |
| PRE 14A | Open PRE 14A document | View SEC filing for PRE 14A | PRE 14A | 15 Mar 2022 | 23 Jun 2022 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Mar 2022 | 04 Mar 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Mar 2022 | 04 Mar 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Mar 2022 | 04 Mar 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Mar 2022 | 04 Mar 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Mar 2022 | 04 Mar 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Mar 2022 | 04 Mar 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Mar 2022 | 04 Mar 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Mar 2022 | 04 Mar 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Mar 2022 | 04 Mar 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Mar 2022 | 04 Mar 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Mar 2022 | 04 Mar 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Mar 2022 | 28 Feb 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Mar 2022 | 28 Feb 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Mar 2022 | 28 Feb 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Mar 2022 | 28 Feb 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Mar 2022 | 28 Feb 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Mar 2022 | 28 Feb 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Mar 2022 | 28 Feb 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Mar 2022 | 28 Feb 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Mar 2022 | 28 Feb 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Mar 2022 | 28 Feb 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Mar 2022 | 28 Feb 2022 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 24 Feb 2022 | 24 Feb 2022 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 15 Feb 2022 | 13 Feb 2022 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SEC SCHEDULE 13G | 11 Feb 2022 | 005-55457 | |
| 5 | Open 5 document | View SEC filing for 5 | FORM 5 SUBMISSION | 10 Feb 2022 | 31 Dec 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 10 Feb 2022 | 08 Feb 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 10 Feb 2022 | 08 Feb 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 10 Feb 2022 | 08 Feb 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 10 Feb 2022 | 08 Feb 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 10 Feb 2022 | 08 Feb 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 10 Feb 2022 | 08 Feb 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 10 Feb 2022 | 08 Feb 2022 | |
| 10-K | Open 10-K document | Open XBRL data | View SEC filing for 10-K | FORM 10-K | 09 Feb 2022 | 31 Dec 2021 | 001-16174 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K | 09 Feb 2022 | 09 Feb 2022 | 001-16174 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 06 Dec 2021 | 24 Nov 2021 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 24 Nov 2021 | 22 Nov 2021 | 001-16174 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 10 Nov 2021 | 09 Nov 2021 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Nov 2021 | 04 Nov 2021 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 04 Nov 2021 | 02 Nov 2021 | 001-16174 |
| 424B5 | Open 424B5 document | View SEC filing for 424B5 | 424B5 | 04 Nov 2021 | 333-260519 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 04 Nov 2021 | 02 Nov 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 03 Nov 2021 | 01 Nov 2021 | |
| FWP | Open FWP document | View SEC filing for FWP | FWP | 02 Nov 2021 | 333-260519 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 02 Nov 2021 | 02 Nov 2021 | 001-16174 |
| 424B3 | Open 424B3 document | View SEC filing for 424B3 | 424B3 | 27 Oct 2021 | 333-260519 | |
| S-3ASR | Open S-3ASR document | View SEC filing for S-3ASR | S-3ASR | 27 Oct 2021 | 333-260519 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 27 Oct 2021 | 30 Sep 2021 | 001-16174 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K | 27 Oct 2021 | 30 Sep 2021 | 001-16174 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 04 Oct 2021 | 01 Oct 2021 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 27 Aug 2021 | 26 Aug 2021 | 001-16174 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 19 Aug 2021 | 15 Aug 2021 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 19 Aug 2021 | 15 Aug 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 Aug 2021 | 10 Aug 2021 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 28 Jul 2021 | 30 Jun 2021 | 001-16174 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K | 28 Jul 2021 | 30 Jun 2021 | 001-16174 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K | 21 Jul 2021 | 21 Jul 2021 | 001-16174 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 06 Jul 2021 | 02 Jul 2021 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 16 Jun 2021 | 14 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 16 Jun 2021 | 14 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 16 Jun 2021 | 14 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 16 Jun 2021 | 14 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 16 Jun 2021 | 14 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 16 Jun 2021 | 14 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 16 Jun 2021 | 14 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 16 Jun 2021 | 14 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 16 Jun 2021 | 14 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 16 Jun 2021 | 14 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 16 Jun 2021 | 14 Jun 2021 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 14 Jun 2021 | 14 Jun 2021 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 10 Jun 2021 | 09 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 10 Jun 2021 | 09 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 10 Jun 2021 | 09 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 10 Jun 2021 | 09 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 10 Jun 2021 | 09 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 10 Jun 2021 | 09 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 10 Jun 2021 | 09 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 10 Jun 2021 | 09 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 10 Jun 2021 | 09 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 10 Jun 2021 | 09 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Jun 2021 | 05 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Jun 2021 | 05 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Jun 2021 | 05 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Jun 2021 | 05 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Jun 2021 | 05 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Jun 2021 | 05 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Jun 2021 | 05 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Jun 2021 | 05 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Jun 2021 | 05 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 25 May 2021 | 21 May 2021 | |
| SD | Open SD document | View SEC filing for SD | FORM SD | 20 May 2021 | 001-16174 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 May 2021 | 11 May 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 May 2021 | 11 May 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 May 2021 | 11 May 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 May 2021 | 11 May 2021 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 28 Apr 2021 | 31 Mar 2021 | 001-16174 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K | 28 Apr 2021 | 31 Mar 2021 | 001-16174 |
| DEFA14A | Open DEFA14A document | View SEC filing for DEFA14A | DEFA14A | 21 Apr 2021 | 001-16174 | |
| DEF 14A | Open DEF 14A document | View SEC filing for DEF 14A | DEF 14A | 21 Apr 2021 | 14 Jun 2021 | 001-16174 |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 21 Apr 2021 | |||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 15 Apr 2021 | |||
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 22 Mar 2021 | |||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 17 Mar 2021 | 16 Mar 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Mar 2021 | 04 Mar 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Mar 2021 | 04 Mar 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Mar 2021 | 04 Mar 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Mar 2021 | 04 Mar 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Mar 2021 | 04 Mar 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Mar 2021 | 05 Mar 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Mar 2021 | 04 Mar 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Mar 2021 | 04 Mar 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Mar 2021 | 04 Mar 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Mar 2021 | 04 Mar 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 04 Mar 2021 | 02 Mar 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 04 Mar 2021 | 03 Mar 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 04 Mar 2021 | 02 Mar 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 04 Mar 2021 | 03 Mar 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 04 Mar 2021 | 03 Mar 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Mar 2021 | 28 Feb 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Mar 2021 | 28 Feb 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Mar 2021 | 28 Feb 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Mar 2021 | 28 Feb 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Mar 2021 | 28 Feb 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Mar 2021 | 28 Feb 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Mar 2021 | 28 Feb 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Mar 2021 | 28 Feb 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Mar 2021 | 28 Feb 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Mar 2021 | 28 Feb 2021 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 17 Feb 2021 | 15 Feb 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 17 Feb 2021 | 14 Feb 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 17 Feb 2021 | 14 Feb 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 17 Feb 2021 | 14 Feb 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 17 Feb 2021 | 14 Feb 2021 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SEC SCHEDULE 13G | 16 Feb 2021 | 005-55457 | |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | SC 13G | 11 Feb 2021 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 11 Feb 2021 | 09 Feb 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 11 Feb 2021 | 09 Feb 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 11 Feb 2021 | 09 Feb 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 11 Feb 2021 | 09 Feb 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 11 Feb 2021 | 09 Feb 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 11 Feb 2021 | 09 Feb 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 11 Feb 2021 | 09 Feb 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 11 Feb 2021 | 09 Feb 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 11 Feb 2021 | 09 Feb 2021 | |
| 10-K | Open 10-K document | Open XBRL data | View SEC filing for 10-K | FORM 10-K | 10 Feb 2021 | 31 Dec 2020 | 001-16174 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K | 10 Feb 2021 | 10 Feb 2021 | 001-16174 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SEC SCHEDULE 13G | 03 Feb 2021 | 005-55457 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 02 Feb 2021 | 31 Jan 2021 | 001-16174 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 25 Jan 2021 | 21 Jan 2021 | 001-16174 |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 05 Nov 2020 | 30 Sep 2020 | 001-16174 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K | 05 Nov 2020 | 05 Nov 2020 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 03 Nov 2020 | 01 Nov 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 10 Sep 2020 | 09 Sep 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 03 Sep 2020 | 02 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 03 Sep 2020 | 01 Sep 2020 | |
| EFFECT | Open EFFECT document | View SEC filing for EFFECT | 17 Aug 2020 | 333-241010 | ||
| 424B3 | Open 424B3 document | View SEC filing for 424B3 | 424B3 | 17 Aug 2020 | 333-241010 | |
| SD | Open SD document | View SEC filing for SD | FORM SD | 14 Aug 2020 | 001-16174 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Aug 2020 | 11 Aug 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Aug 2020 | 11 Aug 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Aug 2020 | 11 Aug 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Aug 2020 | 11 Aug 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Aug 2020 | 11 Aug 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Aug 2020 | 11 Aug 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Aug 2020 | 11 Aug 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Aug 2020 | 11 Aug 2020 | |
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 13 Aug 2020 | |||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 13 Aug 2020 | |||
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 11 Aug 2020 | |||
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 06 Aug 2020 | 04 Aug 2020 | 001-16174 |
| S-4 | Open S-4 document | View SEC filing for S-4 | S-4 | 05 Aug 2020 | 333-241010 | |
| S-8 POS | Open S-8 POS document | View SEC filing for S-8 POS | S-8 POS | 05 Aug 2020 | 333-168331 | |
| S-8 POS | Open S-8 POS document | View SEC filing for S-8 POS | S-8 POS | 05 Aug 2020 | 333-206753 | |
| S-8 POS | Open S-8 POS document | View SEC filing for S-8 POS | S-8 POS | 05 Aug 2020 | 333-212851 | |
| S-8 POS | Open S-8 POS document | View SEC filing for S-8 POS | S-8 POS | 05 Aug 2020 | 333-220382 | |
| S-8 POS | Open S-8 POS document | View SEC filing for S-8 POS | S-8 POS | 05 Aug 2020 | 333-214077 | |
| S-8 | Open S-8 document | View SEC filing for S-8 | S-8 | 05 Aug 2020 | 333-241003 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 05 Aug 2020 | 30 Jun 2020 | 001-16174 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K | 05 Aug 2020 | 05 Aug 2020 | 001-16174 |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 15 Jul 2020 | |||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 19 Jun 2020 | |||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 15 Jun 2020 | 11 Jun 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 15 Jun 2020 | 11 Jun 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 15 Jun 2020 | 11 Jun 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 15 Jun 2020 | 11 Jun 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 15 Jun 2020 | 11 Jun 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 15 Jun 2020 | 11 Jun 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 15 Jun 2020 | 11 Jun 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 15 Jun 2020 | 11 Jun 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 15 Jun 2020 | 11 Jun 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 11 Jun 2020 | 09 Jun 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 11 Jun 2020 | 09 Jun 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 11 Jun 2020 | 09 Jun 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 11 Jun 2020 | 09 Jun 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 11 Jun 2020 | 09 Jun 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 11 Jun 2020 | 09 Jun 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 11 Jun 2020 | 09 Jun 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 11 Jun 2020 | 09 Jun 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 11 Jun 2020 | 09 Jun 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 11 Jun 2020 | 09 Jun 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 11 Jun 2020 | 09 Jun 2020 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 09 Jun 2020 | 09 Jun 2020 | 001-16174 |
| DEFA14A | Open DEFA14A document | View SEC filing for DEFA14A | DEFA14A | 26 May 2020 | 001-16174 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 07 May 2020 | 31 Mar 2020 | 001-16174 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K | 07 May 2020 | 07 May 2020 | 001-16174 |
| DEFA14A | Open DEFA14A document | View SEC filing for DEFA14A | DEFA14A | 22 Apr 2020 | 001-16174 | |
| DEF 14A | Open DEF 14A document | View SEC filing for DEF 14A | DEF 14A | 22 Apr 2020 | 09 Jun 2020 | 001-16174 |
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 17 Apr 2020 | |||
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 31 Mar 2020 | |||
| PRE 14A | Open PRE 14A document | View SEC filing for PRE 14A | PRE 14A | 19 Mar 2020 | 09 Jun 2020 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 19 Mar 2020 | 17 Mar 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 19 Mar 2020 | 17 Mar 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 19 Mar 2020 | 17 Mar 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 19 Mar 2020 | 17 Mar 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 19 Mar 2020 | 17 Mar 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 19 Mar 2020 | 17 Mar 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 19 Mar 2020 | 17 Mar 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 05 Mar 2020 | 04 Mar 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 05 Mar 2020 | 03 Mar 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 05 Mar 2020 | 03 Mar 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 05 Mar 2020 | 03 Mar 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 05 Mar 2020 | 03 Mar 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 04 Mar 2020 | 02 Mar 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 03 Mar 2020 | 28 Feb 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 03 Mar 2020 | 28 Feb 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 03 Mar 2020 | 28 Feb 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 03 Mar 2020 | 28 Feb 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 03 Mar 2020 | 28 Feb 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 03 Mar 2020 | 28 Feb 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 03 Mar 2020 | 28 Feb 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 03 Mar 2020 | 28 Feb 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 03 Mar 2020 | 28 Feb 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 03 Mar 2020 | 28 Feb 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 03 Mar 2020 | 28 Feb 2020 | |
| 10-K | Open 10-K document | Open XBRL data | View SEC filing for 10-K | FORM 10-K | 21 Feb 2020 | 31 Dec 2019 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Feb 2020 | 19 Feb 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 18 Feb 2020 | 14 Feb 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 18 Feb 2020 | 13 Feb 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 18 Feb 2020 | 14 Feb 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 18 Feb 2020 | 14 Feb 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 18 Feb 2020 | 13 Feb 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 18 Feb 2020 | 14 Feb 2020 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 14 Feb 2020 | 005-55457 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Feb 2020 | 11 Feb 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Feb 2020 | 11 Feb 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Feb 2020 | 11 Feb 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Feb 2020 | 11 Feb 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Feb 2020 | 11 Feb 2020 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K | 12 Feb 2020 | 12 Feb 2020 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 11 Feb 2020 | 09 Feb 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 11 Feb 2020 | 09 Feb 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 11 Feb 2020 | 09 Feb 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 11 Feb 2020 | 09 Feb 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 11 Feb 2020 | 09 Feb 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 11 Feb 2020 | 09 Feb 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 11 Feb 2020 | 09 Feb 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 11 Feb 2020 | 09 Feb 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 11 Feb 2020 | 09 Feb 2020 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 05 Feb 2020 | 005-55457 | ||
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | SEC SCHEDULE 13G | 28 Jan 2020 | 005-55457 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Jan 2020 | 31 Dec 2019 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 02 Jan 2020 | 22 Dec 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 03 Dec 2019 | 30 Nov 2019 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | FORM 8-K | 25 Nov 2019 | 25 Nov 2019 | 001-16174 |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | FORM 10-Q | 07 Nov 2019 | 30 Sep 2019 | 001-16174 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K | 07 Nov 2019 | 07 Nov 2019 | 001-16174 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K | 07 Nov 2019 | 07 Nov 2019 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Nov 2019 | 05 Nov 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 05 Nov 2019 | 03 Nov 2019 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K | 23 Oct 2019 | 21 Oct 2019 | 001-16174 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 15 Oct 2019 | 02 Oct 2019 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K | 02 Oct 2019 | 02 Oct 2019 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Sep 2019 | 18 Sep 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Sep 2019 | 18 Sep 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Sep 2019 | 18 Sep 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Sep 2019 | 18 Sep 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Sep 2019 | 18 Sep 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Sep 2019 | 18 Sep 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 11 Sep 2019 | 09 Sep 2019 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | FORM 10-Q | 07 Aug 2019 | 30 Jun 2019 | 001-16174 |
| 8-K | Open 8-K document | View SEC filing for 8-K | TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K | 07 Aug 2019 | 07 Aug 2019 | 001-16174 |
| 8-K | Open 8-K document | View SEC filing for 8-K | TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K | 07 Aug 2019 | 07 Aug 2019 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Jun 2019 | 11 Jun 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Jun 2019 | 11 Jun 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Jun 2019 | 11 Jun 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Jun 2019 | 11 Jun 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Jun 2019 | 11 Jun 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Jun 2019 | 11 Jun 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Jun 2019 | 11 Jun 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Jun 2019 | 11 Jun 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Jun 2019 | 11 Jun 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Jun 2019 | 11 Jun 2019 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 11 Jun 2019 | 11 Jun 2019 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 05 Jun 2019 | 04 Jun 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 03 Jun 2019 | 03 Jun 2019 | |
| SD | Open SD document | View SEC filing for SD | FORM SD | 31 May 2019 | 001-16174 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 21 May 2019 | 18 May 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 May 2019 | 16 May 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 May 2019 | 16 May 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 May 2019 | 16 May 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 May 2019 | 16 May 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 May 2019 | 16 May 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 May 2019 | 16 May 2019 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | FORM 10-Q | 02 May 2019 | 31 Mar 2019 | 001-16174 |
| 8-K | Open 8-K document | View SEC filing for 8-K | TEVA PHARMACEUTICAL INDUSTRIES LTD. 8-K | 02 May 2019 | 02 May 2019 | 001-16174 |
| DEFA14A | Open DEFA14A document | View SEC filing for DEFA14A | DEFA14A | 16 Apr 2019 | 001-16174 | |
| DEF 14A | Open DEF 14A document | View SEC filing for DEF 14A | DEFINITIVE PROXY STATEMENT | 16 Apr 2019 | 11 Jun 2019 | 001-16174 |
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 10 Apr 2019 | 08 Apr 2019 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 19 Mar 2019 | 17 Mar 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 19 Mar 2019 | 17 Mar 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 19 Mar 2019 | 17 Mar 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 19 Mar 2019 | 17 Mar 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 19 Mar 2019 | 17 Mar 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 19 Mar 2019 | 17 Mar 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 19 Mar 2019 | 17 Mar 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 19 Mar 2019 | 17 Mar 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 14 Mar 2019 | 12 Mar 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 14 Mar 2019 | 12 Mar 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 14 Mar 2019 | 12 Mar 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 14 Mar 2019 | 12 Mar 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 14 Mar 2019 | 12 Mar 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 14 Mar 2019 | 12 Mar 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Mar 2019 | 04 Mar 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Mar 2019 | 04 Mar 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Mar 2019 | 04 Mar 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Mar 2019 | 04 Mar 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Mar 2019 | 04 Mar 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Mar 2019 | 04 Mar 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Mar 2019 | 04 Mar 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Mar 2019 | 04 Mar 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Mar 2019 | 04 Mar 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Mar 2019 | 04 Mar 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Mar 2019 | 04 Mar 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Mar 2019 | 04 Mar 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 05 Mar 2019 | 03 Mar 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 05 Mar 2019 | 03 Mar 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 05 Mar 2019 | 03 Mar 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 05 Mar 2019 | 02 Mar 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 05 Mar 2019 | 04 Mar 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 05 Mar 2019 | 03 Mar 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 05 Mar 2019 | 03 Mar 2019 | |
| 10-K | Open 10-K document | Open XBRL data | View SEC filing for 10-K | FORM 10-K | 19 Feb 2019 | 31 Dec 2018 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 19 Feb 2019 | 14 Feb 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 19 Feb 2019 | 14 Feb 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 19 Feb 2019 | 14 Feb 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 19 Feb 2019 | 14 Feb 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 19 Feb 2019 | 14 Feb 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 14 Feb 2019 | 12 Feb 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 14 Feb 2019 | 12 Feb 2019 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 14 Feb 2019 | 12 Feb 2019 | |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | SC 13G | 14 Feb 2019 | 005-55457 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 14 Feb 2019 | 005-55457 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K | 13 Feb 2019 | 13 Feb 2019 | 001-16174 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 28 Jan 2019 | 005-55457 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 03 Jan 2019 | 31 Dec 2018 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 14 Dec 2018 | 14 Dec 2018 | 001-16174 |
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 04 Dec 2018 | 04 Dec 2018 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 04 Dec 2018 | 30 Nov 2018 | |
| EFFECT | Open EFFECT document | View SEC filing for EFFECT | 03 Dec 2018 | 333-228351 | ||
| 8-K | Open 8-K document | View SEC filing for 8-K | TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K | 26 Nov 2018 | 26 Nov 2018 | 001-16174 |
| F-6 | Open F-6 document | View SEC filing for F-6 | 13 Nov 2018 | 333-228351 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Nov 2018 | 05 Nov 2018 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | FORM 10-Q | 01 Nov 2018 | 30 Sep 2018 | 001-16174 |
| 8-K | Open 8-K document | View SEC filing for 8-K | TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K | 01 Nov 2018 | 01 Nov 2018 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 09 Oct 2018 | 02 Mar 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Sep 2018 | 18 Sep 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Sep 2018 | 18 Sep 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Sep 2018 | 18 Sep 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Sep 2018 | 18 Sep 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Sep 2018 | 18 Sep 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 11 Sep 2018 | 09 Sep 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 05 Sep 2018 | 03 Sep 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 05 Sep 2018 | 05 Sep 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 05 Sep 2018 | 03 Sep 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 05 Sep 2018 | 03 Sep 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 05 Sep 2018 | 03 Sep 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Aug 2018 | 09 Aug 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Aug 2018 | 03 Aug 2018 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | FORM 10-Q | 02 Aug 2018 | 30 Jun 2018 | 001-16174 |
| 8-K | Open 8-K document | View SEC filing for 8-K | TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K | 02 Aug 2018 | 02 Aug 2018 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Jun 2018 | 05 Jun 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Jun 2018 | 05 Jun 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Jun 2018 | 05 Jun 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Jun 2018 | 05 Jun 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Jun 2018 | 05 Jun 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Jun 2018 | 05 Jun 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Jun 2018 | 05 Jun 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Jun 2018 | 05 Jun 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Jun 2018 | 05 Jun 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Jun 2018 | 05 Jun 2018 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 07 Jun 2018 | 05 Jun 2018 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 06 Jun 2018 | 05 Jun 2018 | 001-16174 |
| SD | Open SD document | View SEC filing for SD | FORM SD | 31 May 2018 | 001-16174 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 11 May 2018 | 09 May 2018 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 03 May 2018 | 31 Mar 2018 | 001-16174 |
| 8-K | Open 8-K document | View SEC filing for 8-K | TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K | 03 May 2018 | 03 May 2018 | 001-16174 |
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 27 Apr 2018 | 27 Apr 2018 | 001-16174 |
| DEFA14A | Open DEFA14A document | View SEC filing for DEFA14A | DEFA14A | 25 Apr 2018 | 001-16174 | |
| DEF 14A | Open DEF 14A document | View SEC filing for DEF 14A | DEF 14A | 25 Apr 2018 | 05 Jun 2018 | 001-16174 |
| EFFECT | Open EFFECT document | View SEC filing for EFFECT | 19 Apr 2018 | 333-224102 | ||
| EFFECT | Open EFFECT document | View SEC filing for EFFECT | 19 Apr 2018 | 333-222767 | ||
| 424B3 | Open 424B3 document | View SEC filing for 424B3 | PROSPECTUS | 19 Apr 2018 | 333-224102 | |
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 16 Apr 2018 | |||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 16 Apr 2018 | |||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 16 Apr 2018 | |||
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 09 Apr 2018 | |||
| S-4 | Open S-4 document | View SEC filing for S-4 | FORM S-4 | 02 Apr 2018 | 333-224102 | |
| S-3/A | Open S-3/A document | View SEC filing for S-3/A | FORM S-3 AMENDMENT NO. 2 | 28 Mar 2018 | 333-222767 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Mar 2018 | 17 Mar 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Mar 2018 | 17 Mar 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Mar 2018 | 17 Mar 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Mar 2018 | 17 Mar 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Mar 2018 | 17 Mar 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Mar 2018 | 17 Mar 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Mar 2018 | 17 Mar 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Mar 2018 | 17 Mar 2018 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 14 Mar 2018 | 14 Mar 2018 | 001-16174 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 14 Mar 2018 | 12 Mar 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 14 Mar 2018 | 12 Mar 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 14 Mar 2018 | 12 Mar 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 14 Mar 2018 | 12 Mar 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 14 Mar 2018 | 12 Mar 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 14 Mar 2018 | 12 Mar 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Mar 2018 | 03 Mar 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Mar 2018 | 03 Mar 2018 | |
| 3/A | Open 3/A document | View SEC filing for 3/A | FORM 3/A SUBMISSION | 06 Mar 2018 | 01 Jan 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Mar 2018 | 03 Mar 2018 | |
| 3/A | Open 3/A document | View SEC filing for 3/A | FORM 3/A SUBMISSION | 06 Mar 2018 | 01 Jan 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Mar 2018 | 03 Mar 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Mar 2018 | 04 Mar 2018 | |
| 3/A | Open 3/A document | View SEC filing for 3/A | FORM 3/A SUBMISSION | 06 Mar 2018 | 01 Jan 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Mar 2018 | 03 Mar 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Mar 2018 | 03 Mar 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Feb 2018 | 14 Feb 2018 | |
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 16 Feb 2018 | |||
| S-3/A | Open S-3/A document | View SEC filing for S-3/A | S-3/A | 16 Feb 2018 | 333-222767 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 13 Feb 2018 | 005-55457 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 Feb 2018 | 09 Feb 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 Feb 2018 | 09 Feb 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 Feb 2018 | 09 Feb 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 Feb 2018 | 09 Feb 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 Feb 2018 | 09 Feb 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 Feb 2018 | 09 Feb 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 Feb 2018 | 09 Feb 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 Feb 2018 | 09 Feb 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 Feb 2018 | 09 Feb 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 Feb 2018 | 09 Feb 2018 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 Feb 2018 | 09 Feb 2018 | |
| 3/A | Open 3/A document | View SEC filing for 3/A | FORM 3/A SUBMISSION | 12 Feb 2018 | 01 Jan 2018 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 12 Feb 2018 | 06 Feb 2018 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 12 Feb 2018 | 06 Feb 2018 | |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SCHEDULE 13D AMENDMENT NO. 4 | 12 Feb 2018 | 005-55457 | |
| 10-K | Open 10-K document | Open XBRL data | View SEC filing for 10-K | FORM 10-K | 12 Feb 2018 | 31 Dec 2017 | 001-16174 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 09 Feb 2018 | 005-55457 | |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | SC 13G | 09 Feb 2018 | 005-55457 | |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 09 Feb 2018 | |||
| 8-K | Open 8-K document | View SEC filing for 8-K | TEVA PHARMACEUTICAL INDUSTRIES LTD. 8-K | 08 Feb 2018 | 08 Feb 2018 | 001-16174 |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | 05 Feb 2018 | 005-55457 | ||
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 01 Feb 2018 | 01 Feb 2018 | 001-16174 |
| 8-K | Open 8-K document | View SEC filing for 8-K | TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K | 01 Feb 2018 | 01 Feb 2018 | 001-16174 |
| S-3 | Open S-3 document | View SEC filing for S-3 | FORM S-3 | 29 Jan 2018 | 333-222767 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 23 Jan 2018 | 19 Jan 2018 | |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SCHEDULE 13D AMENDMENT NO. 3 | 12 Jan 2018 | 005-55457 | |
| 3/A | Open 3/A document | View SEC filing for 3/A | FORM 3/A SUBMISSION | 08 Jan 2018 | 01 Jan 2018 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | FORM 8-K | 04 Jan 2018 | 04 Jan 2018 | 001-16174 |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 03 Jan 2018 | 02 Jan 2018 | 001-16174 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 02 Jan 2018 | 01 Jan 2018 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 02 Jan 2018 | 01 Jan 2018 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 02 Jan 2018 | 01 Jan 2018 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 02 Jan 2018 | 01 Jan 2018 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 02 Jan 2018 | 01 Jan 2018 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 02 Jan 2018 | 01 Jan 2018 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 02 Jan 2018 | 01 Jan 2018 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 02 Jan 2018 | 01 Jan 2018 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 02 Jan 2018 | 01 Jan 2018 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 02 Jan 2018 | 01 Jan 2018 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 02 Jan 2018 | 01 Jan 2018 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 02 Jan 2018 | 01 Jan 2018 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 02 Jan 2018 | 01 Jan 2018 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 02 Jan 2018 | 01 Jan 2018 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 02 Jan 2018 | 01 Jan 2018 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 02 Jan 2018 | 01 Jan 2018 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 02 Jan 2018 | 01 Jan 2018 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 02 Jan 2018 | 01 Jan 2018 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 02 Jan 2018 | 01 Jan 2018 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 02 Jan 2018 | 01 Jan 2018 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 02 Jan 2018 | 01 Jan 2018 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 02 Jan 2018 | 01 Jan 2018 | |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 27 Dec 2017 | 27 Dec 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 18 Dec 2017 | 18 Dec 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 15 Dec 2017 | 15 Dec 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | FORM 6-K | 14 Dec 2017 | 14 Dec 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 13 Dec 2017 | 13 Dec 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 12 Dec 2017 | 12 Dec 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 11 Dec 2017 | 11 Dec 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 29 Nov 2017 | 29 Nov 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 27 Nov 2017 | 27 Nov 2017 | 001-16174 |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SC 13D/A | 13 Nov 2017 | 005-55457 | |
| 6-K | Open 6-K document | Open XBRL data | View SEC filing for 6-K | FORM 6-K | 02 Nov 2017 | 02 Nov 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 02 Nov 2017 | 02 Nov 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K | 02 Nov 2017 | 02 Nov 2017 | 001-16174 |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SC 13D/A | 01 Nov 2017 | 005-55457 | |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 01 Nov 2017 | 01 Nov 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 31 Oct 2017 | 31 Oct 2017 | 001-16174 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 31 Oct 2017 | ||
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | SC 13G | 31 Oct 2017 | ||
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 30 Oct 2017 | 30 Oct 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 26 Oct 2017 | 26 Oct 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 19 Oct 2017 | 19 Oct 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 17 Oct 2017 | 17 Oct 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 10 Oct 2017 | 10 Oct 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 04 Oct 2017 | 04 Oct 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 25 Sep 2017 | 25 Sep 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 25 Sep 2017 | 25 Sep 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | FORM 6-K | 19 Sep 2017 | 19 Sep 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 19 Sep 2017 | 19 Sep 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 18 Sep 2017 | 18 Sep 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 18 Sep 2017 | 18 Sep 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 14 Sep 2017 | 14 Sep 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 12 Sep 2017 | 12 Sep 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 11 Sep 2017 | 11 Sep 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 11 Sep 2017 | 11 Sep 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | 11 Sep 2017 | 11 Sep 2017 | 001-16174 | |
| S-8 | Open S-8 document | View SEC filing for S-8 | FORM S-8 | 07 Sep 2017 | 333-220382 | |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 06 Sep 2017 | 06 Sep 2017 | 001-16174 |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SC 13D/A | 05 Sep 2017 | ||
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 05 Sep 2017 | 05 Sep 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 30 Aug 2017 | 30 Aug 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 18 Aug 2017 | 18 Aug 2017 | 001-16174 |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 15 Aug 2017 | |||
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 07 Aug 2017 | 07 Aug 2017 | 001-16174 |
| 6-K | Open 6-K document | Open XBRL data | View SEC filing for 6-K | FORM 6-K | 03 Aug 2017 | 03 Aug 2017 | 001-16174 |
| 6-K | Open 6-K document | Open XBRL data | View SEC filing for 6-K | TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K | 03 Aug 2017 | 03 Aug 2017 | 001-16174 |
| 6-K | Open 6-K document | Open XBRL data | View SEC filing for 6-K | TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K | 31 Jul 2017 | 31 Jul 2017 | 001-16174 |
| 6-K | Open 6-K document | Open XBRL data | View SEC filing for 6-K | LIVE FILING | 28 Jul 2017 | 28 Jul 2017 | 001-16174 |
| 6-K | Open 6-K document | Open XBRL data | View SEC filing for 6-K | LIVE FILING | 24 Jul 2017 | 24 Jul 2017 | 001-16174 |
| 6-K | Open 6-K document | Open XBRL data | View SEC filing for 6-K | LIVE FILING | 20 Jul 2017 | 20 Jul 2017 | 001-16174 |
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 14 Jul 2017 | |||
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 13 Jul 2017 | 13 Jul 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 11 Jul 2017 | 11 Jul 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 11 Jul 2017 | 11 Jul 2017 | 001-16174 |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 03 Jul 2017 | |||
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 29 Jun 2017 | 29 Jun 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 29 Jun 2017 | 29 Jun 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 27 Jun 2017 | 27 Jun 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 12 Jun 2017 | 12 Jun 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 09 Jun 2017 | 09 Jun 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | FORM 6-K | 08 Jun 2017 | 08 Jun 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 07 Jun 2017 | 07 Jun 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 06 Jun 2017 | 06 Jun 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 01 Jun 2017 | 01 Jun 2017 | 001-16174 |
| SD | Open SD document | View SEC filing for SD | FORM SD | 31 May 2017 | 001-16174 | |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 31 May 2017 | 31 May 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 17 May 2017 | 17 May 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 17 May 2017 | 17 May 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 15 May 2017 | 15 May 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 15 May 2017 | 15 May 2017 | 001-16174 |
| 6-K | Open 6-K document | Open XBRL data | View SEC filing for 6-K | FORM 6-K | 11 May 2017 | 11 May 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6-K | 11 May 2017 | 11 May 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 05 May 2017 | 05 May 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 05 May 2017 | 05 May 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 27 Apr 2017 | 27 Apr 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 26 Apr 2017 | 26 Apr 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 26 Apr 2017 | 26 Apr 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 20 Apr 2017 | 20 Apr 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 19 Apr 2017 | 19 Apr 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 13 Apr 2017 | 13 Apr 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 06 Apr 2017 | 06 Apr 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 03 Apr 2017 | 03 Apr 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 16 Mar 2017 | 16 Mar 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 13 Mar 2017 | 13 Mar 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 06 Mar 2017 | 06 Mar 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 01 Mar 2017 | 01 Mar 2017 | 001-16174 |
| 6-K | Open 6-K document | View SEC filing for 6-K | LIVE FILING | 28 Feb 2017 | 28 Feb 2017 | 001-16174 |
About this filer
TEVA PHARMACEUTICAL INDUSTRIES LTD files with the SEC under CIK 0000818686. This page aggregates EDGAR filings and related ownership activity.
Industry: Pharmaceutical Preparations.
FAQ
- What is a CIK?
- A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
- Why are some filings missing?
- New filings appear as the SEC updates EDGAR, and older records can vary by availability.
- How often is this page updated?
- Updates follow new EDGAR submissions and periodic data refreshes.